Bli medlem
Bli medlem

Du är här

2017-10-26

IDL Biotech: Claes Henning New Scientific Advisor to IDL Biotech AB

IDL Biotech continues to strengthen its scientific knowledge by
appointing an additional experienced scientific advisor.

Professor Claes Henning is Associate Professor in Clinical
Bacteriology from Umeå University. He started his career at The
National Bacteriology Laboratory (SBL) in 1962, and has since been
devoted to clinical microbiology and infectious diseases. Professor
Henning has worked with clinical trials of antibiotics and
diagnostics as well as quality improvement in laboratory operations.
Professor Henning has more than 100 publications.

Beyond working at several Swedish hospitals, Claes also worked in
United Arab Emirates (UAE) for over fifteen years, including Ministry
of Health, General Health Services, Health Authority Abu Dhabi and
Dubai Healthcare Authority.

Professor Hennings extended experience will help IDL Biotech to ensure
that our current and future research is based on appropriate and
validated methodologies. His appointment is a testimony to the
importance we place on the scientific validity and robustness of our
products.

"We are very excited to have Professor Henning as a part of our team.
His extensive experience and knowledge within bacteriology will help
IDL achieve its scientific goals, says Charlotte Berg, CEO at IDL
Biotech AB.

"We are delighted to include both Professor Henning and Professor
Abrahamsson in our team. Clearly their deep scientific expertise as
well as their contacts and overall knowledge base will be extremely
helpful", says Hans Örström, Chairman of the Board.

For further information please contact:
IDL Biotech AB (publ)
Charlotte Berg, CEO
+46 8 799 67 50

IDL Biotech AB (publ) är ett publikt svenskt bioteknikbolag,
specialiserat på in vitro diagnostik inom onkologi och bakteriologi.
Bolaget utvecklar, producerar och marknadsför unika och
kostnadseffektiva produkter för medicinskt angelägna indikationer.
IDL Biotech AB (publ) har ett etablerat internationellt
distributörsnätverk. Bolagets aktier (IDL B) är noterade på
Aktietorget.

-----------------------------------------------------------
http://news.cision.com/se/idl-biotech/r/claes-henning-new-scientific-adv...
http://mb.cision.com/Main/11534/2376217/742144.pdf

Författare Aktietorget

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.